$PAYXBullishMed

Citi sees 40% gain for this fintech, likes its big dividend payout too

Citi upgraded Paychex (PAYX) to buy from neutral and raised its price target to $140 from $99, implying about 39% upside from Friday’s close. Analyst Bryan Keane cited AI-driven client retention, pricing opportunities, and lower delivery costs, plus a slight macro tailwind. Citi expects organic revenue growth to accelerate in FY27. Paychex recently increased its dividend by 10% to $1.19/share.

7/10
4/10
Med
Bullish
ahead of Paychex earnings later this month
bullish (upgrade + higher target + dividend support)

Street read-through shifts toward accelerating organic revenue growth and dividend-supported downside protection.

Citi upgraded Paychex to buy and raised its price target to $140, citing AI-driven retention, pricing, and cost reductions.

Near-term upside bias versus consensus as investors reprice growth expectations and dividend floor.

Background

Paychex has reportedly fallen 34% over the past 12 months amid concerns about operating costs and labor-market health.

Why it matters

Citi argues AI solutions are improving retention and lowering delivery costs, and expects organic revenue growth to accelerate in FY27, with the dividend increase reducing downside risk.

Market relevance

Sell-side sentiment turns more constructive ahead of upcoming earnings, potentially influencing positioning and expectations.

Market effects

Supports the broader payroll/HR services narrative that AI can improve retention and unit economics.

No specific regional impact described.

No explicit global linkage beyond general macro/labor-market framing.

Alternative perspectives

The upgrade may be premature if operating-cost concerns or labor-market health deteriorate, limiting the durability of the FY27 acceleration call.

The macro tailwind is described as slight; if new-business starts slow, the AI/booking-growth thesis could underperform despite the dividend cushion.

Key entities

  • Paychex

    Citi upgraded the stock to buy, raised its price target to $140, and cited AI-driven retention/pricing and cost improvements.

  • Citi

    Issued the upgrade and price-target hike referenced in the article.

  • Bryan Keane

    Cited for the note’s thesis on AI solutions, bookings growth, and dividend downside support.

Related articles

$PAYXMedAI 8/10

Paychex tops fourth quarter earnings, shares dip on 2027 outlook

Paychex reported fiscal Q4 results that beat expectations: adjusted diluted EPS rose to $1.32 (vs. $1.31 est.) and revenue increased 12% to $1.61B (vs. $1.60B). Shares fell about 2% after the company’s fiscal 2027 outlook. Paychex forecast 2027 revenue growth of 5%–6% and adjusted EPS up 7%–9% to about $5.90–$6.01, citing Paycor HCM integration and AI investment.

$PAYXMedAI 8/10

Why Paychex (PAYX) Shares Are Sliding Today

Paychex shares fell about 2.2% in the morning after the company reported fourth-quarter adjusted EPS of $1.32, slightly above the $1.31 estimate, and revenue of $1.61 billion, matching expectations. Paychex guided for fiscal-year revenue growth of 5%–6% versus 12.5% in the quarter, and adjusted EPS growth of 7%–9%, leading investors to sell.

$PAYXMed

PAYCHEX INC (PAYX): Results of Operations and Financial Condition

PAYCHEX INC (PAYX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 payx-ex99_1.htm EX-99.1 EX-99.1 News Release 911 Panorama Trail South • Rochester, NY 14625 • paychex.com Paychex Reports Fourth Quarter and Full-Year 2026 Results • Delivered Strong Double-Digit Revenue and Earnings Growth • Expanded AI Leadership with the Launch of WI

SK Hynix's US listing sparks rush of single-stock ETF filings

Reuters reports that at least 10 fund managers, including Direxion and ProShares, filed to launch single-stock ETFs tracking SK Hynix after the chipmaker starts trading in the US. Most filings target leveraged and inverse funds tied to SK Hynix’s Nasdaq-listed ADRs. SK Hynix raised $26.5 billion and is due to begin trading Friday.